Cargando…

Delivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures

BACKGROUND: Electrospun drug-eluting fabrics have enormous potential for the delivery of physicochemically diverse drugs in combination by controlling the underlying material chemistry and fabric microarchitecture. However, the rationale for formulating drugs at high drug loading in the same or sepa...

Descripción completa

Detalles Bibliográficos
Autores principales: Blakney, Anna K, Krogstad, Emily A, Jiang, Yonghou H, Woodrow, Kim A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069153/
https://www.ncbi.nlm.nih.gov/pubmed/24971008
http://dx.doi.org/10.2147/IJN.S61664
_version_ 1782322520140021760
author Blakney, Anna K
Krogstad, Emily A
Jiang, Yonghou H
Woodrow, Kim A
author_facet Blakney, Anna K
Krogstad, Emily A
Jiang, Yonghou H
Woodrow, Kim A
author_sort Blakney, Anna K
collection PubMed
description BACKGROUND: Electrospun drug-eluting fabrics have enormous potential for the delivery of physicochemically diverse drugs in combination by controlling the underlying material chemistry and fabric microarchitecture. However, the rationale for formulating drugs at high drug loading in the same or separate fibers is unknown but has important implications for product development and clinical applications. METHODS: Using a production-scale free-surface electrospinning instrument, we produced electrospun nanofibers with different microscale geometries for the co-delivery of tenofovir (TFV) and levonorgestrel (LNG) – two lead drug candidates for multipurpose prevention of HIV acquisition and unintended pregnancy. We investigated the in vitro drug release of TFV and LNG combinations from composites that deliver the two drugs from the same fiber (combined fibers) or from separate fibers in a stacked or interwoven architecture. For stacked composites, we also examined the role that fabric thickness has on drug-release kinetics. We also measured the cytotoxicity and antiviral activity of the drugs delivered alone and in combination. RESULTS: Herein, we report on the solution and processing parameters for the free-surface electrospinning of medical fabrics with controlled microarchitecture and high drug loading (up to 20 wt%). We observed that in vitro release of the highly water-soluble TFV, but not the water-insoluble LNG, was affected by composite microarchitecture, fabric thickness, and drug content. Finally, we showed that the drug-loaded nanofibers are noncytotoxic and that the antiviral activity of TFV is preserved through the electrospinning process and when combined with LNG. CONCLUSION: Electrospun fabrics with high drug loading create multicomponent systems that benefit from the independent control of the nanofibrous microarchitecture. Our findings are significant because they will inform the design and production of composite electrospun fabrics for the co-delivery of physicochemically diverse drugs that may be useful for multipurpose prevention.
format Online
Article
Text
id pubmed-4069153
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-40691532014-06-26 Delivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures Blakney, Anna K Krogstad, Emily A Jiang, Yonghou H Woodrow, Kim A Int J Nanomedicine Original Research BACKGROUND: Electrospun drug-eluting fabrics have enormous potential for the delivery of physicochemically diverse drugs in combination by controlling the underlying material chemistry and fabric microarchitecture. However, the rationale for formulating drugs at high drug loading in the same or separate fibers is unknown but has important implications for product development and clinical applications. METHODS: Using a production-scale free-surface electrospinning instrument, we produced electrospun nanofibers with different microscale geometries for the co-delivery of tenofovir (TFV) and levonorgestrel (LNG) – two lead drug candidates for multipurpose prevention of HIV acquisition and unintended pregnancy. We investigated the in vitro drug release of TFV and LNG combinations from composites that deliver the two drugs from the same fiber (combined fibers) or from separate fibers in a stacked or interwoven architecture. For stacked composites, we also examined the role that fabric thickness has on drug-release kinetics. We also measured the cytotoxicity and antiviral activity of the drugs delivered alone and in combination. RESULTS: Herein, we report on the solution and processing parameters for the free-surface electrospinning of medical fabrics with controlled microarchitecture and high drug loading (up to 20 wt%). We observed that in vitro release of the highly water-soluble TFV, but not the water-insoluble LNG, was affected by composite microarchitecture, fabric thickness, and drug content. Finally, we showed that the drug-loaded nanofibers are noncytotoxic and that the antiviral activity of TFV is preserved through the electrospinning process and when combined with LNG. CONCLUSION: Electrospun fabrics with high drug loading create multicomponent systems that benefit from the independent control of the nanofibrous microarchitecture. Our findings are significant because they will inform the design and production of composite electrospun fabrics for the co-delivery of physicochemically diverse drugs that may be useful for multipurpose prevention. Dove Medical Press 2014-06-17 /pmc/articles/PMC4069153/ /pubmed/24971008 http://dx.doi.org/10.2147/IJN.S61664 Text en © 2014 Blakney et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Blakney, Anna K
Krogstad, Emily A
Jiang, Yonghou H
Woodrow, Kim A
Delivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures
title Delivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures
title_full Delivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures
title_fullStr Delivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures
title_full_unstemmed Delivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures
title_short Delivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures
title_sort delivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069153/
https://www.ncbi.nlm.nih.gov/pubmed/24971008
http://dx.doi.org/10.2147/IJN.S61664
work_keys_str_mv AT blakneyannak deliveryofmultipurposepreventiondrugcombinationsfromelectrospunnanofibersusingcompositemicroarchitectures
AT krogstademilya deliveryofmultipurposepreventiondrugcombinationsfromelectrospunnanofibersusingcompositemicroarchitectures
AT jiangyonghouh deliveryofmultipurposepreventiondrugcombinationsfromelectrospunnanofibersusingcompositemicroarchitectures
AT woodrowkima deliveryofmultipurposepreventiondrugcombinationsfromelectrospunnanofibersusingcompositemicroarchitectures